These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9417725)

  • 1. [Olanzapine. A new antipsychotic agent].
    Bredkjoer SR; Gerlach J
    Ugeskr Laeger; 1997 Nov; 159(48):7160-4. PubMed ID: 9417725
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose olanzapine therapy in schizophrenia.
    Alao AO; Armenta WA; Yolles JC
    Ann Pharmacother; 1999 Nov; 33(11):1228. PubMed ID: 10573326
    [No Abstract]   [Full Text] [Related]  

  • 3. The effectiveness of combining lithium with olanzapine in the treatment of resistant schizophrenia.
    Martín JC; Palenciano G; Pérez R
    J Clin Psychiatry; 2000 Dec; 61(12):948. PubMed ID: 11206602
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical antipsychotics and cognition in schizophrenia.
    Sharma T
    Arch Gen Psychiatry; 2002 Jun; 59(6):571-2; author reply 573-5. PubMed ID: 12044209
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment noncompliance with orally disintegrating olanzapine tablets.
    Freudenreich O
    Can J Psychiatry; 2003 Jun; 48(5):353-4. PubMed ID: 12866351
    [No Abstract]   [Full Text] [Related]  

  • 6. Olanzapine for schizophrenia.
    Med Lett Drugs Ther; 1997 Jan; 39(992):5-6. PubMed ID: 9008682
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine on trial.
    Capehart BP; Holsinger T
    Am J Psychiatry; 1998 Jan; 155(1):152; author reply 153-5. PubMed ID: 9433357
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine-induced manic-like syndrome.
    Lindenmayer JP; Klebanov R
    J Clin Psychiatry; 1998 Jun; 59(6):318-9. PubMed ID: 9671347
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse effects of high-dose olanzapine in treatment-refractory schizophrenia.
    Bronson BD; Lindenmayer JP
    J Clin Psychopharmacol; 2000 Jun; 20(3):382-4. PubMed ID: 10831029
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine: keep an eye on this neuroleptic.
    Leblanc G
    Can Fam Physician; 2000 Aug; 46():1565-6, 1569. PubMed ID: 10955171
    [No Abstract]   [Full Text] [Related]  

  • 11. Clozapine to olanzapine.
    Millson RC; Delva NJ
    Am J Psychiatry; 1999 Jul; 156(7):1121. PubMed ID: 10401476
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose olanzapine for treatment-refractory schizophrenia.
    Sheitman BB; Lindgren JC; Early J; Sved M
    Am J Psychiatry; 1997 Nov; 154(11):1626. PubMed ID: 9356581
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine: a novel atypical neuroleptic agent.
    Reus VI
    Lancet; 1997 May; 349(9061):1264-5. PubMed ID: 9142055
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of cervical dystonia by olanzapine.
    Kuniyoshi M; Ohyama S; Otsuka M; Nishi S; Inanaga K; Mori N
    Hum Psychopharmacol; 2003 Jun; 18(4):311-2. PubMed ID: 12766936
    [No Abstract]   [Full Text] [Related]  

  • 15. Olanzapine.
    Hale AS
    Br J Hosp Med; 1997 Nov 5-18; 58(9):442-5. PubMed ID: 9619205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Olanzapine--a new atypical neuroleptic. A chance for advancement in the therapy of schizophrenia].
    Nervenarzt; 1997 Jul; 68(7 Suppl Olanzapin):1-8. PubMed ID: 9431360
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of recent clinical studies with olanzapine.
    Tollefson GD; Kuntz AJ
    Br J Psychiatry Suppl; 1999; (37):30-5. PubMed ID: 10211139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of novel agents in the treatment of schizophrenia and a look to the future].
    Keks NA
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Jun; 18(3):97-101. PubMed ID: 9800201
    [No Abstract]   [Full Text] [Related]  

  • 19. A possible association between high normal and high dose olanzapine and prolongation of the PR interval.
    Kosky N
    J Psychopharmacol; 2002 Jun; 16(2):181-2. PubMed ID: 12095078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of olanzapine as first-line schizophrenia therapy.
    Cohen LJ
    Am J Health Syst Pharm; 1999 Aug; 56(15):1559-60, 1563-4. PubMed ID: 10478999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.